DHR

Danaher Corp

D
DHR
USD
-1.68
(-0.6776%)
Market Closed
102,938.00
Volume
7.425
EPS
0.38
Div Yield
45.267
P/E
177,844,971,196.25
Market Cap
Today
-0.5613%
1 Week
0.231%
1 Month
-8.396%
6 Months
-1.013%
12 Months
24.231%
Year To Date
6.404%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
ABT
ABT
-1.475
(-1.263%)
USD
TMO
TMO
-4.75
(-0.847%)
USD
BDX
BDX
-13.09
(-5.4521%)
USD
BSX
BSX
0.16
(0.1845%)
USD
ISRG
ISRG
4.01
(0.7705%)
USD
MDT
MDT
-3.04
(-3.3348%)
USD
SYK
SYK
0.72
(0.195%)
USD
GE
GE
-0.35
(-0.1953%)
USD
JNJ
JNJ
-2.8
(-1.755%)
USD
PFE
PFE
0.105
(0.3839%)
USD

Title:
Danaher Corp

Sector:
Healthcare
Industry:
Diagnostics & Research
Danaher Corp. is a diversified medical conglomerate that specializes in the design, manufacture and sales of medical, industrial, as well as commercial products and services. The company is named after Danaher Creek in Western Montana, where founders Steven M. Rales and Mitchell Rales conceptualized the company and its name while fishing. The firm was one of the original firms in North America to adopt Japanese “Kaizen” manufacturing principles that focus on continuous improvement and reduction of waste. The company operates in the following platforms: Life Sciences, Diagnostics and Environmental & Applied Solutions. Danaher Corp. has been ranked as high as 130th on the Fortune 500 list of top American companies by revenue. The company is headquartered in Washington DC.
Do you need help or have a question?
Contact Us